## AND MASAO OMATA~ The effect of ursodeoxycholic acid on liver function tests and on bile acid metabolism was investigated in a multi-center randomized controlled dose study for chronic hepatitis C. Twenty, 18 and 19 patients were administered 150, 600 and 900 mglday, respectively of ursodeoxycho
Ursodeoxycholic acid treatment of hepatic steatosis: a 13C NMR metabolic study
✍ Scribed by Patrícia M. Nunes; John G. Jones; Anabela P. Rolo; Carlos M. M. Palmeira; Rui A. Carvalho
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 761 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0952-3480
- DOI
- 10.1002/nbm.1672
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The effect of ursodeoxycholic acid administration on liver function tests and on bile acid metabolism was investigated in 18 patients with chronic active hepatitis. Three different doses of ursodeoxycholic acid-250 mg, 500 mg and 750 mg-were administered daily to each patient for consecutive 2-mo pe
## Abstract The ^1^H and ^13^C NMR spectra of carminic acid were completely assigned, thus confirming its structure and the conformation of the glucose residue.
We describe an improved perfusion system designed for NMR studies with 13C-labeled metabolites Using this system we have monitored the uptake and metabolism of [ I3C]acetate and ['3Crplucose in pooled human lymphocytes cas1 in an agar-gel thread. o 1986 Academic Rm Inc
## Abstract The fate of the ^13^C label arising from [ U‐^13^C ] succinate in rabbit renal proximal convoluted tubular (PCT) cells, incubated with [U‐^13^C]succinate, was investigated by ^13^C NMR spectroscopy of the perchloric acid extracts of the cell pellets. The ^13^C label of [U‐^13^C] succina
Non-alcohol-induced steatohepatitis (NASH) is characterized by elevated serum aminotransferase activities with hepatic steatosis, inflammation, and occasionally fibrosis that may progress to cirrhosis. No established treatment exists for this potentially serious disorder. Our aim was to conduct a pi